Patents covering BioVie’s terlipressin liquid formulation now secured in the United States, India, Japan and Chile, and are pending in eight additional markets Liquid formulation has demonstrated room ...

Biomarker NBR1 shows promise in predicting liver cancer patients' response to immunotherapy, potentially improving treatment ...

Liver function discovery may pave the way for improved treatments of cardiovascular diseases, offering new insights into ...

We treat every type of cancer, including the most important one: yours. With cancer, where you get treated first matters. From diagnosis to treatment, our experts provide the care and support you need ...

An FDA AdCom in September recommended against full approval for Ocaliva by a 13-1 vote for the treatment of primary biliary ...

Discover why Sagimet Biosciences' Denifanstat is a top contender in treating MASH, with FDA designation and strong financials ...

A new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for ...

Early signs of male breast cancer are often subtle but should not be ignored. Common symptoms include: The most common sign ...

According to B.C. Transplant data, in 2023, 199 people who received an organ transplant in a transplant centre in Vancouver ...

Liver cancer is the sixth leading cause cancer death in the U.S. The most common type of liver cancer in adults is ...

While the treatment options for this aggressive type ... which are linked to liver cirrhosis and other serious health ... Mechanism of Action of the Hepatitis B and D Virus Cell Entry Inhibitor ...

Liver fibrosis causes scar tissue to form on the liver, sometimes leading to chronic liver disease. Learn about noninvasive ...